7 JCI-accredited hospitals 17 hospitals with oncology 65 oncology specialists 19 clinical trials recruiting
Oncology & Cancer Care
Prof. Bülent Karabulut, MD
Medical Oncology

Prof. Bülent Karabulut, MD

Prof. Bülent Karabulut, MD is a medical oncology specialist at Acibadem Kent Hospital (Izmir). He has more than 33 years of experience in medicine and focuses on ovarian cancer, cervical cancer, pancreatic cancer and…

  • Experience33+ years
  • HospitalKent Hospital (Izmir)
  • LanguagesTurkish, English
  • FocusMedical Oncology

About

Prof. Bülent Karabulut, MD is a medical oncologist at Acibadem Kent Hospital in İzmir, where he works in the Medical Oncology Department. He has more than 33 years in medicine, and his clinical practice covers a broad range of solid tumors, including cancers of the breast, gastrointestinal system, gynecological organs, urinary system, liver, biliary tract, and peritoneum.

Dr. Karabulut graduated from Ege University Faculty of Medicine in 1993. He completed his Internal Medicine training there in 1999 and his Medical Oncology training in 2001. He became an Associate Professor in 2006 and a Professor in 2011. His career includes medical oncology cell research laboratory work at Ege University Faculty of Medicine beginning in 1997, and roles at Kent Oncology Center at Private Kent Hospital, where he served as General Coordinator and Medical Oncology Specialist. He joined Acıbadem Healthcare Services in 2023. He is a founding member of the Ege Hematology Oncology Association (EHOD) and the Interdisciplinary Oncology Association (İDOD) and has served as vice president of both. He has held board positions at the Turkish Medical Oncology Association, the Turkish Oncology Group Association, the Turkish Lung Cancer Association (where he also served as general secretary), the Head and Neck Cancers Association, and Ege University Cancer Research Center. He is a member of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). He has chaired a digestive system tumors working group, held regional representative duties, served as advisory faculty to a young researchers working group, and been a member of education, accreditation, drug safety, and blood transfusion commissions.

Clinical focus

Dr. Karabulut’s clinical work centers on the medical oncology management of solid tumors. In gynecologic oncology, this includes ovarian cancer, cervical cancer, and endometrial cancer. In gastrointestinal oncology, he treats pancreatic cancer, esophageal cancer, stomach cancer, liver cancer, gallbladder and bile duct cancers, and peritoneal cancer. His practice also covers bladder cancer, kidney cancer, and breast cancer.

Medical oncology addresses the drug-based treatment of cancer and its coordination with other disciplines where relevant. Any recommendation depends on the individual diagnosis, disease stage, prior treatment, and the patient’s overall health, and is determined after review of the complete medical record.

How Dr. Karabulut works with international patients

Dr. Karabulut consults in Turkish and English. The Acibadem international patient team coordinates the transfer of medical reports and the scheduling of appointments before a patient’s visit. A first consultation typically covers the patient’s medical history, existing pathology and imaging reports, previous treatments, and current symptoms, followed by a discussion of possible next steps, which may include further tests before a treatment plan can be discussed. Video consultation is available for international patients who wish to have an initial review or a follow-up discussion from their home country.

Expertise

Conditions treated

  • Ovarian cancer
  • Cervical cancer
  • Pancreatic cancer
  • Esophageal cancer
  • Stomach cancer
  • Bladder cancer
  • Breast cancer
  • Skin cancer

Procedures and treatments

  • Peritoneal cancer
  • Ovarian cancer treatment
  • Cervical cancer treatment
  • Pancreatic cancer treatment
  • Esophageal cancer treatment
  • Stomach cancer treatment
  • Bladder cancer treatment
  • Breast cancer treatment

Education and career

Timeline

  1. 2023Acıbadem Healthcare ServicesCareer
  2. 2011ProfessorEducation
  3. 2006Associate ProfessorlikEducation
  4. 2001Ege University Faculty of Medicine Medical OncologyEducation
  5. 1999Ege University Faculty of Medicine Internal MedicineEducation
  6. 1997Ege Faculty of Medicine Medical Oncology cell research laboratory studiesCareer
  7. 1993Ege University Faculty of MedicineEducation

Memberships

  • Board membership responsible for Young Oncologists
  • Education commission membership and regional representative duties
  • Accreditation Board Commission membership within Ege University
  • Vice presidency duties at EHOD and IDOD
  • Membership in numerous domestic and international associations, including cancer-related non-governmental organizations
  • Chairmanship of the digestive system tumors working group and regional representation
  • Board membership at the Turkish Medical Oncology Association
  • Board membership at Ege University Cancer Research Center
  • Education commission membership
  • Board membership at the Head and Neck Cancers Association
  • Board membership at the Turkish Oncology Group Association
  • Advisory faculty membership of the young researchers working group
  • Drug safety commission membership
  • Memberships in the European Medical Oncology Association (ESMO) and the American Clinical Oncology Association (ASCO)
  • Board membership and general secretaryship at the Turkish Lung Cancer Association
  • Founding membership of Ege Hematology Oncology Association (EHOD) and Interdisciplinary Oncology Association (İDOD)
  • Board membership at Ege University Cancer Research Center
  • Blood transfusion commission membership

Tumour boards

Cancer types where Prof. Bülent Karabulut, MD is part of the specialist team

This page is general information from Acıbadem oncology teams and does not replace a consultation. Treatment decisions are made after a review of your reports by a tumour board.

Second opinion · Free case review

Send your reports and get a plan from a tumour board, not a single doctor

Pathology, imaging and previous treatment history are enough to start. Written recommendation within 48 hours, including trial eligibility.